GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (FRA:YB4P) » Definitions » Other Gross PPE

Savara (FRA:YB4P) Other Gross PPE : €2.11 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Savara Other Gross PPE?

Savara's Other Gross PPE for the quarter that ended in Dec. 2024 was €2.11 Mil.

Savara's quarterly Other Gross PPE declined from Jun. 2024 (€0.22 Mil) to Sep. 2024 (€0.19 Mil) but then increased from Sep. 2024 (€0.19 Mil) to Dec. 2024 (€2.11 Mil).

Savara's annual Other Gross PPE increased from Dec. 2022 (€1.81 Mil) to Dec. 2023 (€1.99 Mil) and increased from Dec. 2023 (€1.99 Mil) to Dec. 2024 (€2.11 Mil).


Savara Other Gross PPE Historical Data

The historical data trend for Savara's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savara Other Gross PPE Chart

Savara Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.65 1.77 1.81 1.99 2.11

Savara Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 0.23 0.22 0.19 2.11

Savara Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Savara Business Description

Traded in Other Exchanges
Address
1717 Langhorne Newtown Road, Suite 300, Langhorne, PA, USA, 19047
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Savara Headlines

No Headlines